Colfax Corporation Form 10-Q Summary
Reporting period: Three and nine months ended September 25, 2015, compared with the corresponding periods ended September 26, 2014. The provided filing identifies the registrant as Colfax Corporation, not Enovis CORP. Colfax operated through Gas and Fluid Handling and Fabrication Technology, providing industrial gas-, fluid-handling, welding and cutting products and services.
Financial performance and liquidity
| Metric | Q3 2015 | Q3 2014 | 9M 2015 | 9M 2014 |
|---|---|---|---|---|
| Net sales | $969.1 million | $1,164.5 million | $2,905.6 million | $3,418.1 million |
| Gross profit | $295.9 million | $373.2 million | $918.3 million | $1,087.0 million |
| Gross margin | 30.5% | 32.0% | 31.6% | 31.8% |
| Operating income | $45.6 million | $118.8 million | $219.6 million | $302.2 million |
| Net income attributable to Colfax | $18.4 million | $73.4 million | $123.5 million | $312.0 million |
| Diluted EPS | $0.15 | $0.59 | $0.99 | $2.38 |
| Operating cash flow | Not separately provided | Not separately provided | $152.1 million | $201.5 million |
Quarterly revenue declined 16.8%, while nine-month revenue declined 15.0%. Operating income declined 61.7% in the quarter and 27.3% year to date. The nine-month 2014 results benefited from approximately $120 million of noncash tax benefit related to the reassessment of U.S. deferred tax asset valuation allowances and a $22.7 million tax benefit from the resolution of unrecognized tax benefits; this makes year-over-year earnings comparisons less meaningful.
Net income available to common shareholders was reduced by foreign currency effects, lower volumes and product mix, restructuring costs, impairment charges, higher doubtful-account provisions and asbestos-related charges. The 2015 nine-month effective tax rate was 24.0%, compared with a tax benefit in the 2014 period.
Cash and cash equivalents were $221.2 million at September 25, 2015, down from $305.4 million at December 31, 2014. Nine-month operating cash flow was $152.1 million, capital expenditures were $32.7 million and acquisition spending was $184.5 million, primarily for Roots. Cash flow also reflected $10.5 million of net asbestos-related cash outflows, $32.6 million of pension contributions and $33.0 million of restructuring payments.
Total debt was $1.55 billion, including $1.53 billion of long-term debt. The company had $586.5 million available under its revolving credit facility, $363.1 million of outstanding letters of credit and $80.0 million outstanding under a receivables financing facility. The company stated that it was in compliance with its debt covenants and believed available liquidity was adequate for the next twelve months.
Material changes versus the prior comparable period
- Foreign currency translation reduced third-quarter and nine-month sales by approximately 12% and reduced income before taxes by approximately 14%. Other comprehensive loss included $217.4 million of foreign currency translation loss for the first nine months.
- Existing-business sales declined $76.0 million in the quarter and $259.2 million for the nine months, reflecting lower volumes and weaker demand in several end markets.
- Gas and Fluid Handling sales declined 14.7% in the quarter and 17.5% for the nine months; segment operating margin fell to 5.5% from 11.9% in the quarter and to 9.0% from 9.9% year to date.
- Fabrication Technology sales declined 18.8% in the quarter and 12.5% for the nine months; segment operating margin fell to 8.7% from 12.0% in the quarter and to 10.3% from 11.9% year to date.
- On June 30, 2015, Colfax acquired the Roots blowers and compressors business for approximately $185 million, adding $84.1 million of preliminary goodwill and approximately $35.2 million of nine-month sales.
- The company refinanced its senior secured credit facility on June 5, 2015 and increased the revolving commitment by $300 million to $1.3 billion on September 25, 2015.
- Interest expense declined to $10.9 million from $14.9 million in the quarter and to $37.2 million from $40.9 million for the nine months, although 2015 included a $4.7 million write-off of financing fees and original issue discount.
Guidance, outlook, risks and unusual items
- Management expected approximately $40 million of additional restructuring and related charges during the remainder of 2015.
- Management noted that gas- and fluid-handling shipments historically peak in the fourth quarter as customers use annual capital budgets, although European operations typically slow during holiday periods.
- Unusual or material items included a $4.1 million pretax asbestos-related charge, a $9.4 million increase in allowances for doubtful South American accounts, approximately $4.3 million of asset impairment charges, and approximately $5.0 million of Roots transaction costs and first-year amortization.
- Asbestos liabilities totaled $407.0 million, partly offset by current and long-term insurance assets and receivables totaling approximately $407.5 million. Management cautioned that claim frequency, settlement costs, insurance coverage and insurer solvency could cause actual results to differ materially.
- There were 22,132 unresolved asbestos claims at September 25, 2015. A pending appellate matter could reduce expected insurance recovery by an estimated range from minimal to $30 million, depending on the applicable allocation methodology.
- Key operating risks included cyclical industrial markets, oil and commodity prices, foreign exchange, acquisition integration, restructuring execution, raw-material availability, product liability, cybersecurity, pension funding, tax matters and restrictive debt covenants.
- Approximately $213.1 million of cash was held outside the United States and could be subject to tax or other restrictions if repatriated.
- After the quarter, the board authorized a $100 million share repurchase program through December 31, 2016; 663,349 shares had been repurchased through October 21, 2015.
Important facts for investors to verify
- Confirm the issuer identity: the supplied filing is for Colfax Corporation, whereas the request metadata names Enovis CORP.
- Assess the sustainability of earnings excluding the unusually favorable 2014 tax benefits and considering 2015 restructuring, impairment, asbestos, credit-refinancing and acquisition-related costs.
- Review leverage, covenant compliance, variable-rate exposure and the December 21, 2015 scheduled termination date of the $80 million receivables financing facility.
- Evaluate Roots integration, acquisition accounting and the potential for additional goodwill or intangible-asset impairment.
- Monitor foreign exchange sensitivity, including the disclosed estimated $350 million reduction in equity from a 10% depreciation in major currencies relative to the U.S. dollar.
- Review asbestos claims, insurance recoveries, appellate proceedings and the adequacy of recorded reserves.
- Consider working-capital cash usage, pension contributions, restructuring payments and the concentration of liquidity outside the United States.